Lung immune signatures define two groups of end-stage IPF patients
Background: The role of the immune system in the pathobiology of Idiopathic Pulmonary Fibrosis (IPF) is controversial.
Methods: To investigate it, we calculated immune signatures with Gene Set Variation Analysis (GSVA) and applied them to the lung transcriptome followed by unbiased cluster analysis of GSVA immune-enrichment scores, in 109 IPF patients from the Lung Tissue Research Consortium (LTRC). Results were validated experimentally using cell-based methods (flow cytometry) in lung tissue of IPF patients from the University of Pittsburgh (n = 26). Finally, differential gene expression and hypergeometric test were used to explore non-immune differences between clusters.
Results: We identified two clusters (C#1 and C#2) of IPF patients of similar size in the LTRC dataset. C#1 included 58 patients (53%) with enrichment in GSVA immune signatures, particularly cytotoxic and memory T cells signatures, whereas C#2 included 51 patients (47%) with an overall lower expression of GSVA immune signatures (results were validated by flow cytometry with similar unbiased clustering generation). Differential gene expression between clusters identified differences in cilium, epithelial and secretory cell genes, all of them showing an inverse correlation with the immune response signatures. Notably, both clusters showed distinct features despite clinical similarities.
Conclusions: In end-stage IPF lung tissue, we identified two clusters of patients with very different levels of immune signatures and gene expression but with similar clinical characteristics. Weather these immune clusters differentiate diverse disease trajectories remains unexplored.
Puedes leer el artículo completo aquí: https://pubmed.ncbi.nlm.nih.gov/37770891/
Authors: Tamara Cruz, Núria Mendoza, Sandra Casas-Recasens, Guillaume Noell, Fernanda Hernandez-Gonzalez, Alejandro Frino-Garcia, Xavi Alsina-Restoy, María Molina, Mauricio Rojas, Alvar Agustí, Jacobo Sellares, Rosa Faner.
Noticias relacionadas
Peripheral Immune Cell Profiling Reveals Distinct Immune Hallmarks in Progressive Pulmonary Fibrosis
This study shows that patients with f-ILDs several immune populations in circulating blood, skewed toward an aged and exhausted immune profile, relate to lung function impairment at diagnosis, and that PPF is associated with an increased cytotoxic immune response.
Iron accumulation drives fibrosis, senescence and the senescence-associated secretory phenotype
Fibrogenesis is part of a normal protective response to tissue injury that can become irreversible and progressive, leading to fatal diseases.
Human senescent fibroblasts trigger fibrogenic reaction in the lungs of immunodeficient mice
A new research paper was published on the cover of Aging (listed by MEDLINE/PubMed as «Aging (Albany NY)» and «Aging-US» by Web of Science) Volume 15, Issue 14, entitled, «Human senescent fibroblasts trigger progressive lung fibrosis in mice.»
Artículos
Fibrosis
- 768786·Mate Maus et al. Iron accumulation drives fibrosis, senescence and the senescence-associated secretory phenotype
- 769072·Tamara Cruz et Al. – Lung immune signatures define two groups of end-stage IPF patients
- 769275·Nuria Mendoza et al. Blood Immunophenotypes of Idiopathic Pulmonary Fibrosis: Relationship with Disease Severity and Progression
- 779185·Vincent Cottin et Al. Syndrome of Combined Pulmonary Fibrosis and Emphysema. An Official ATS/ERS/JRS/ALAT Research Statement.
- 779376·Gerard J. Criner, Alvar Agusti, Hossein Borghaei, Joseph Friedberg, Fernando J. Martinez, Curtis Miyamoto, Claus F. Vogelmeier, Bartolome R. Celli.Chronic Obstructive Pulmonary Disease and Lung Cancer: A Review for Clinicians
Imagen otenida de la publicación original.